Z-Sar-OSu

Catalog No. :
ACSGVX170
CAS No. :
53733-96-3
Molecular Formula :
C15H16N2O6
Molecular Weight :
320.30

IUPAC Name:2,5-dioxopyrrolidin-1-yl N-((benzyloxy)carbonyl)-N-methylglycinate

Z-Sar-OSu structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$136.00Login to see priceInquiryInquiry
5g97%$407.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameZ-Sar-OSu
IUPAC Name2,5-dioxopyrrolidin-1-yl N-((benzyloxy)carbonyl)-N-methylglycinate
MDL No.MFCD00153340
Molecular FormulaC15H16N2O6
Molecular Weight320.30
SMILESO=C(OCC1=CC=CC=C1)N(CC(ON2C(CCC2=O)=O)=O)C
InChI KeyGUHSSKCYLZIGBH-UHFFFAOYSA-N
SynonymZ-N-METHYLGLYCINE N-HYDROXYSUCCINIMIDE ESTER;Z-N-ME-GLY-OSU;Z-SARCOSINE N-HYDROXYSUCCINIMIDE ESTER;Z-SARCOSINE-OSU;Z-SAR-OSU;NALPHA-Benzyloxycarbonyl-L-sarcosine N-hydroxysuccinimide ester;N-alpha-Benzyloxycarbonyl-sarcosine succinimidyl ester, N-alpha-Benzyloxycarbonyl-N-alpha-Methyl-glycine succinimidyl ester;Z-N-methylglycine N-hydroxysuccinimide ester Z-sarcosine N-hydroxysuccinimide ester
CAS No.53733-96-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSGVX170 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACSGVX170 route product structure diagram
    ACSGVX17053733-96-3
Inquiry

2. ACSGVX170 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSGVX170 route product structure diagram
    ACSGVX17053733-96-3
Inquiry

Comments (0)